Cargando…

Increased demand for amphetamine treatment in rural Australia

BACKGROUND: A substantial increase in substance treatment episodes for methamphetamine problems suggests characteristics of the treatment population could have changed and that targeted treatment programs are required. To determine who methamphetamine treatment should be designed for this study has...

Descripción completa

Detalles Bibliográficos
Autores principales: Allan, Julaine, Ip, Ryan H. L., Kemp, Michael, Snowdon, Nicole
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6442410/
https://www.ncbi.nlm.nih.gov/pubmed/30929641
http://dx.doi.org/10.1186/s13722-019-0144-6
_version_ 1783407704211980288
author Allan, Julaine
Ip, Ryan H. L.
Kemp, Michael
Snowdon, Nicole
author_facet Allan, Julaine
Ip, Ryan H. L.
Kemp, Michael
Snowdon, Nicole
author_sort Allan, Julaine
collection PubMed
description BACKGROUND: A substantial increase in substance treatment episodes for methamphetamine problems suggests characteristics of the treatment population could have changed and that targeted treatment programs are required. To determine who methamphetamine treatment should be designed for this study has two aims. First, to empirically describe changes in amphetamine treatment presentations to a rural NSW drug and alcohol treatment agency over time. Second, to examine how these characteristics may affect the likelihood of being treated for amphetamines compared to other drugs. METHOD: The Australian Alcohol and Other Drug Treatment Services National Minimum Data Set (AODTS-NMDS) containing closed treatment episodes from a single agency from three time periods was used. Characteristics of people receiving amphetamine treatments in these three periods were compared and the effects of these characteristics on the odds of being treated for amphetamine were estimated using a logistic regression model. The characteristics utilised in the analysis include age, sex, Indigenous status, usual accommodation, living arrangement, source of referral and source of income. RESULTS: The proportion of amphetamine treatment episodes doubled from 2006/2007 to 2015/2016 and overtook alcohol as the most commonly treated principal drug of concern. The estimated proportion of amphetamine treatments showed an increment across all ages and for men and women. It was found that younger people, women, people in temporary accommodation or homeless, people who were self-referred and people whose main source of income was not through employment are more likely to be treated for amphetamine use. CONCLUSION: Significant changes over time in the age, sex and Indigenous status of people receiving treatment for amphetamine as the principal drug of concern requires service delivery to match demand from younger people, particularly women; and Indigenous people. The needs and preferences for treatment of younger women who use amphetamine will be important factors in treatment planning service providers who are more used to providing treatment for young men who use cannabis and older men who use alcohol. Further research on women’s experiences in treatment and outcomes would be useful for informing treatment practices. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13722-019-0144-6) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6442410
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-64424102019-04-11 Increased demand for amphetamine treatment in rural Australia Allan, Julaine Ip, Ryan H. L. Kemp, Michael Snowdon, Nicole Addict Sci Clin Pract Research BACKGROUND: A substantial increase in substance treatment episodes for methamphetamine problems suggests characteristics of the treatment population could have changed and that targeted treatment programs are required. To determine who methamphetamine treatment should be designed for this study has two aims. First, to empirically describe changes in amphetamine treatment presentations to a rural NSW drug and alcohol treatment agency over time. Second, to examine how these characteristics may affect the likelihood of being treated for amphetamines compared to other drugs. METHOD: The Australian Alcohol and Other Drug Treatment Services National Minimum Data Set (AODTS-NMDS) containing closed treatment episodes from a single agency from three time periods was used. Characteristics of people receiving amphetamine treatments in these three periods were compared and the effects of these characteristics on the odds of being treated for amphetamine were estimated using a logistic regression model. The characteristics utilised in the analysis include age, sex, Indigenous status, usual accommodation, living arrangement, source of referral and source of income. RESULTS: The proportion of amphetamine treatment episodes doubled from 2006/2007 to 2015/2016 and overtook alcohol as the most commonly treated principal drug of concern. The estimated proportion of amphetamine treatments showed an increment across all ages and for men and women. It was found that younger people, women, people in temporary accommodation or homeless, people who were self-referred and people whose main source of income was not through employment are more likely to be treated for amphetamine use. CONCLUSION: Significant changes over time in the age, sex and Indigenous status of people receiving treatment for amphetamine as the principal drug of concern requires service delivery to match demand from younger people, particularly women; and Indigenous people. The needs and preferences for treatment of younger women who use amphetamine will be important factors in treatment planning service providers who are more used to providing treatment for young men who use cannabis and older men who use alcohol. Further research on women’s experiences in treatment and outcomes would be useful for informing treatment practices. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13722-019-0144-6) contains supplementary material, which is available to authorized users. BioMed Central 2019-04-01 2019 /pmc/articles/PMC6442410/ /pubmed/30929641 http://dx.doi.org/10.1186/s13722-019-0144-6 Text en © The Author(s) 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Allan, Julaine
Ip, Ryan H. L.
Kemp, Michael
Snowdon, Nicole
Increased demand for amphetamine treatment in rural Australia
title Increased demand for amphetamine treatment in rural Australia
title_full Increased demand for amphetamine treatment in rural Australia
title_fullStr Increased demand for amphetamine treatment in rural Australia
title_full_unstemmed Increased demand for amphetamine treatment in rural Australia
title_short Increased demand for amphetamine treatment in rural Australia
title_sort increased demand for amphetamine treatment in rural australia
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6442410/
https://www.ncbi.nlm.nih.gov/pubmed/30929641
http://dx.doi.org/10.1186/s13722-019-0144-6
work_keys_str_mv AT allanjulaine increaseddemandforamphetaminetreatmentinruralaustralia
AT ipryanhl increaseddemandforamphetaminetreatmentinruralaustralia
AT kempmichael increaseddemandforamphetaminetreatmentinruralaustralia
AT snowdonnicole increaseddemandforamphetaminetreatmentinruralaustralia